Read more
Location: United States, California, South San Francisco
Total raised: $141M
Investors 3
| Date | Name | Website |
| - | Biobrit | biobrit.co... |
| 08.02.2024 | Alpha Wave... | alphawaveg... |
| 11.07.2022 | Yarrow Cap... | yarrow.io |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.08.2021 | Series B | $116M | - |
| 14.09.2020 | Series A | $25M | - |
Mentions in press and media 11
| Date | Title | Description |
| 06.02.2024 | Attralus Closes $56 Million Financing | - |
| 13.09.2021 | Digital health news, funding roundup in the prior week; September 13 | Beauty Pie raised $100 million; Homage landed $30M; DotCom Therapy picked up $13M Cleveland Clinic: Cleveland Clinic is an Ohio-based medical center that combines clinical and hospital care with research and education. Anthem is teaming up ... |
| 09.09.2021 | Attralus Closes $116M in Series B Financing | Attralus, Inc., a South San Francisco, Calif.-based clinical stage biopharmaceutical company developing medicines to improve the lives of patients with systemic amyloidosis, closed a $116m Series B financing. The round was led by Logos Capi... |
| 09.09.2021 | Daily funding roundup - September 9th, 2021 | Affinity secured $80M; CookUnity raised $47M; Juno picks up $20M; DotCom Therapy landed $13M Attralus: Attralus is a South San Francisco-based biotech focused on systemic amyloidosis. Attralus has raised $116 million in Series B funding. Lo... |
| 08.09.2021 | Attralus Closes $116 Million Series B Financing | - Proceeds to advance pipeline of transformational pan-amyloid removal (PAR) therapeutics into the clinic - Financing led by Logos Capital and included other leading public healthcare funds - Appoints Alexander Denner, Ph.D., and Jake Bauer... |
| 15.09.2020 | US based biopharmaceutical company Attralus raises US$ 25M Series A funding | - |
| 14.09.2020 | The Crunchbase News Briefing: Mon., Sept. 14 | 10 Shares Email Facebook Twitter LinkedIn Here’s what you need to know today in startup and venture news, updated by the Crunchbase News staff throughout the day to keep you in the know. Subscribe to the Crunchbase Daily Oracle wins bid for... |
| 14.09.2020 | Attralus Raises $25M in Series A Financing | Attralus, a South San Francisco, CA-based biopharmaceutical company focused on creating medicines for systemic amyloidosis, raised $25m in Series A financing. The round was led by venBio Partners. The company intends to use the funds to fur... |
| 14.09.2020 | Attralus Launches with $25M Series A Funding | SOUTH SAN FRANCISCO, CA, Attralus announced the completion of its $25M Series A financing, led by venBio Partners. >> Click here for more funding data on Attralus >> To export Attralus funding data to PDF and Excel, click he... |
| 14.09.2020 | Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis |
Show more